
~inactive account~ @VHIO & @CancerCoreEU | @LSE_editors | former @NatureMedicine @sloan_kettering @idibell_cat | @unav @UAM_Madrid
Barcelona, Spain
Joined December 2011
- Tweets1.9K
- Following829
- Followers2.8K
- Likes10.6K
Javier Carmona 🇪🇺 retweeted
.@FJCarmonas @VHIO #CCE CSO, joined a roundtable at @SCOPEsummit to discuss real-world examples of network-driven innovation & insights on scaling research through collaboration🤝
@DKFZ @IstTumori @karolinskainst @GustaveRoussy @NCT_HD @NKI_nl
Javier Carmona 🇪🇺 retweeted
🌍 VHIO is participating in the @CancerCoreEU Annual Meeting 2025 at @NKI_nl. A key event to continue advancing research and innovation in oncology.
#CCEAM25
Javier Carmona 🇪🇺 retweeted
📢 Dr. @DirenaAC receives an @ERC_Research Consolidator Grant to study how #inflammation fuels tumor initiation and evolution.
💡With €2M over the next 5 years, the IGNITE Project will dive deep into #PancreaticCancer to tackle early diagnosis and the development of more efficient treatments.
➡️bit.ly/4eZozXa
#CancerResearch #ERCconsolidator
Javier Carmona 🇪🇺 retweeted
✨ Gustave Roussy & Friends avec le Vall d'Hebron Institute of Oncology (#VHIO)✨
Aujourd'hui, @GustaveRoussy a reçu les experts internationaux du @VHIO, dans le cadre du @CancerCoreEU, afin de partager leurs connaissances sur des sujets clés en #cancérologie.
Au programme :
🤖 Intelligence Artificielle (#IA) en recherche préclinique
🔬 Progrès des biopsies liquides
👩⚕️ Place de la chirurgie dans les parcours de soins en oncologie
🧬 Innovations en thérapies cellulaires
⚠️ Prévention et après-cancer
🩻 Imagerie médicale et radiothérapie
🔍 Recherche translationnelle et exploratoire
Merci à toutes et tous pour ces moments d'échanges et de partage.
📸 Photo : Karim Fizazi, Alejandro Piris, Elena Chavarria, Fabrice Barlesi, Emma Pailler, Josep Tabernero, Christophe Massard, Javier Carmona, Fabrice André.
Javier Carmona 🇪🇺 retweeted
“Immunotherapy for Early-Stage Triple-Negative Breast Cancer” is a must read editorial in @NEJM by my @DanaFarber @DrHBurstein. The Editorial has broad applications for testing IO in high-risk cancers in general ! Kudos Hal! nejm.org/doi/full/10.1056/NE…
Javier Carmona 🇪🇺 retweeted
Very excited to share our latest publication on the role of NOTCH1 in sexual dimorphism in liver cancer and published in @CD_AACR! Super proud of @KatieLindblad1 for leading this study as part of her outstanding PhD work.
Now online in @CD_AACR: NOTCH1 Drives Sexually Dimorphic Immune Responses in #HepatocellularCarcinoma - by @KatieLindblad1 @AmaiaLujambio and colleagues doi.org/10.1158/2159-8290.CD…
@IcahnMountSinai @TischCancer
Javier Carmona 🇪🇺 retweeted
Chimeric antigen receptor T-cell (CAR-T) therapy, already approved for certain blood cancers, is generating excitement in early tests against autoimmune diseases. Designed to wipe out a whole class of immune cells, the treatment holds promise but comes with potentially serious risks.
Learn more: bit.ly/4i9FXf1 @NewsfromScience
Javier Carmona 🇪🇺 retweeted
How can you increase the impact of your own research beyond the publication impact factor? 🤔
Our podcast guests @IACR_DIR, @FJCarmonas & Caroline Dive (@CRUKLungCentre) discuss this in episode 7 of The Cancer Researcher Podcast: magazine.eacr.org/make-your-…
#CancerResearch
Shifting from a profit-driven model to one that prioritizes affordability and access to advanced medicines for #patients.
A timely and much needed Perspective by Melinda Kliegman and colleagues @igisci “A roadmap for affordable genetic medicines” nature.com/articles/s41586-0… @Nature
Josep Ramoneda: "Elon Musk dispone de un poder que no había tenido ningún otro empresario en el capitalismo"
@eldiarioes @neustomas eldiario.es/128_b417e6
3
396
Javier Carmona 🇪🇺 retweeted
Amid the uncertainty, here’s what Trump’s victory might mean for U.S. science | Science | AAAS science.org/content/article/…
Javier Carmona 🇪🇺 retweeted
Alarmantes datos: “seis de cada diez oncólogos europeos presentan signos de agotamiento psicológico, un 25% se plantean cambiar su carrera y más de un tercio (38%) contemplan dejar la profesión”. @_SEOM @myESMO
abc.es/sociedad/oncologos-qu…
Javier Carmona 🇪🇺 retweeted
A recent study suggests that reexpression of a protein found during fetal development plays a role in the suppression of immunity in early colorectal adenomas and cancers. Read the full study: nej.md/3ZzbEHH
We have an open postdoc position in my group! The projects of the lab are focused on understanding how cancer genomes dictate immune responses, tumor evolution, and therapy resistance. Come join us in a great environment!
vhio.net/2024/09/18/ref-2024…
1
369
Javier Carmona 🇪🇺 retweeted
We have an open postdoc position in my group! The projects of the lab are focused on understanding how cancer genomes dictate immune responses, tumor evolution, and therapy resistance. Come join us in a great environment!
vhio.net/2024/09/18/ref-2024…
Javier Carmona 🇪🇺 retweeted
About to kick off #ESMO2024 in Barcelona.
Looking fwd to catching up with friends, connecting with new colleagues and establishing new #Partnerships with @CancerCoreEU
Learn more about #CancerCoreEurope in our recent paper @CD_AACR: aacrjournals.org/cancerdisco… #CancerResearch
Javier Carmona 🇪🇺 retweeted
Great turnout at the #CCE Clinical Trials & Translational Research reception in Barcelona! It was wonderful to see the working group come together to connect and network. Many thanks to all attendees ✨
#ESMO24 #ClinicalTrials #CCE_DART #BoBTrial
Javier Carmona 🇪🇺 retweeted
🩸🧬 Willing to learn more about #ctDNA development in #GIST?
Please come by to this #MeetTheExpert at #ESMO24 with me and Dr. Giovanni Grignani ✍️
🗓 Today 15/09
🕒 4-5pm
🪧 Marbella Auditorium cc5






























